Santarus, Inc. (NASDAQ:SNTS) Investor Alert: Lawsuit to Halt Takeover by Salix Pharmaceuticals
An investor, who currently hold shares of shares of Santarus, Inc. (NASDAQ:SNTS) filed a lawsuit in effort to halt the proposed takeover of Santarus, Inc. by Salix Pharmaceuticals, Ltd for $32.00 per share.
View full press release